Home >

Welcome to ASCO Connection Discussion

The ASCO Connection Discussion forum is a space for oncology professionals and others with an interest in cancer care to ask and answer questions about every aspect of the field, from professional development advice to clinical conundrums. Everyone is welcome to participate: to ask a question or leave a response, first log in with your ASCO username and password. Please read the Discussion and Commenting Guidelines before you post a question or response. Contact our staff by email for assistance with the Discussion forum.

Filter by All Topics
ASCO International Affairs
Jul 22, 2016 3:19 PM
In the spring of 2015, ASCO partnered with local organizers to hold its first two Cancer Control in Primary Care (CCPC) courses. One year later, follow-up surveys were sent to participants to assess the impact the course had on their practices.
The first CCPC was held in Bhopal, India in March 2015...
Trainee & Early-Career Oncology
Jocelyn Torres De Yao, MD
Jul 13, 2016 12:59 PM
I'm just wondering if it is advisable for early career oncologist, and if they qualify, to be volunteers for one of the ASCO committee.  Several committee seems interesting and I have yet to review the requirement but was hoping someone can share a personal input regarding the commitment required...
Molecular Oncology Tumor Board
ASCO University
Jul 13, 2016 9:27 AM
Read more to answer the following questions:

According to WHO 2016 criteria, what is the most accurate diagnosis and how do we distinguish ET from PMF in era of molecular studies? Does it matter to distinguish early primary myelofibrosis from essential thrombocythemia for management?
How would we...
ASCO International Affairs
Jun 30, 2016 12:22 PM
ASCO partnered with local organizers to hold three Multidisciplinary Cancer Management Courses (MCMC) between February and April 2016. The evaluation results for these courses indicate that the majority of respondents intend to make practice changes and gained new knowledge and skills as a result...
Molecular Oncology Tumor Board
ASCO University
Jun 15, 2016 8:26 AM
Read more to answer the following questions: 1) What is the significance of the patient having only a partial resection of an ologodendroglioma? 2) What is the importance of the 1p19q co-deletion status of the tumor?